Investors Buy Shares of Danaher (DHR) on Weakness

Share on StockTwits

Traders bought shares of Danaher Co. (NYSE:DHR) on weakness during trading on Wednesday. $129.85 million flowed into the stock on the tick-up and $62.07 million flowed out of the stock on the tick-down, for a money net flow of $67.78 million into the stock. Of all stocks tracked, Danaher had the 20th highest net in-flow for the day. Danaher traded down ($0.12) for the day and closed at $129.74

Several equities research analysts recently commented on DHR shares. Royal Bank of Canada reaffirmed a “hold” rating and set a $102.00 target price on shares of Danaher in a research note on Wednesday, December 19th. Needham & Company LLC initiated coverage on Danaher in a research note on Wednesday, January 2nd. They issued a “buy” rating and a $114.00 price objective for the company. Cowen reissued a “buy” rating and issued a $110.00 price objective on shares of Danaher in a research note on Monday, January 7th. Janney Montgomery Scott raised Danaher from a “neutral” rating to a “buy” rating in a research note on Monday, February 25th. Finally, UBS Group raised their price objective on Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $123.31.

The company has a quick ratio of 1.07, a current ratio of 1.47 and a debt-to-equity ratio of 0.34. The firm has a market cap of $92.85 billion, a price-to-earnings ratio of 29.22, a P/E/G ratio of 2.39 and a beta of 1.04.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. Danaher had a return on equity of 11.64% and a net margin of 13.33%. The company had revenue of $5.40 billion for the quarter, compared to analyst estimates of $5.33 billion. During the same quarter last year, the company earned $1.19 earnings per share. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, equities analysts forecast that Danaher Co. will post 4.76 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date is Thursday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.16. Danaher’s dividend payout ratio (DPR) is currently 14.16%.

In other news, EVP Daniel L. Comas sold 97,357 shares of the firm’s stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $127.04, for a total value of $12,368,233.28. Following the transaction, the executive vice president now owns 134,039 shares in the company, valued at $17,028,314.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Rainer Blair sold 37,859 shares of the firm’s stock in a transaction that occurred on Wednesday, February 27th. The shares were sold at an average price of $127.45, for a total value of $4,825,129.55. Following the completion of the transaction, the insider now owns 32,661 shares in the company, valued at approximately $4,162,644.45. The disclosure for this sale can be found here. Insiders sold 183,150 shares of company stock worth $23,279,637 in the last 90 days. Corporate insiders own 11.90% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Advisor Partners LLC boosted its stake in Danaher by 17.3% during the 4th quarter. Advisor Partners LLC now owns 19,477 shares of the conglomerate’s stock valued at $2,008,000 after purchasing an additional 2,868 shares during the last quarter. Xact Kapitalforvaltning AB lifted its holdings in shares of Danaher by 0.9% during the 4th quarter. Xact Kapitalforvaltning AB now owns 107,127 shares of the conglomerate’s stock valued at $11,047,000 after buying an additional 908 shares during the period. BKD Wealth Advisors LLC bought a new position in shares of Danaher during the 4th quarter valued at $253,000. Stokes Capital Advisors LLC lifted its holdings in shares of Danaher by 15.0% during the 4th quarter. Stokes Capital Advisors LLC now owns 21,215 shares of the conglomerate’s stock valued at $2,188,000 after buying an additional 2,775 shares during the period. Finally, Securian Asset Management Inc lifted its holdings in shares of Danaher by 1.8% during the 4th quarter. Securian Asset Management Inc now owns 63,391 shares of the conglomerate’s stock valued at $6,537,000 after buying an additional 1,128 shares during the period. Institutional investors and hedge funds own 77.98% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was first published by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://weekherald.com/2019/03/22/investors-buy-shares-of-danaher-dhr-on-weakness.html.

About Danaher (NYSE:DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

See Also: How much can an individual set aside as a catch-up contribution?

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.